Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-034414
Filing Date
2022-10-28
Accepted
2022-10-28 16:20:28
Documents
1
Period of Report
2022-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3359
  Complete submission text file 0000899243-22-034414.txt   4708
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address APELLIS PHARMACEUTICALS, INC. 100 5TH AVENUE, 3RD FLOOR WALTHAM MA 02451
Business Address
Brown Victoria L. (Reporting) CIK: 0001810475 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 221342184